Our Science & Technology
Miora Health is transforming maternal care through personalized, AI-powered insights that enable early detection and prevention.
Many pregnancy complications don’t show symptoms until it’s too late. Traditional screening often overlooks the early biological shifts that signal risk.
Miora detects these early changes giving patients and providers time to act, before symptoms begin.
Research shows that imbalances in the maternal microbiome are linked to complications like gestational diabetes, preterm birth, and preeclampsia — often before symptoms appear.
Exploring the influence of microbiota on gestational diabetes and its potential as a biomarker
Front. Bacteriol. · 2024Gut microbiome in gestational diabetes: a cross-sectional study of mothers and offspring 5 years postpartum
Acta Obstet Gynecol Scand · 2018The pregnancy microbiome and preterm birth
Semin Immunopathol. 2020Association between gut microbiota and preeclampsia-eclampsia: a two-sample Mendelian randomization study
BMC Med · 2020
We use the latest next-generation sequencing technology, such as Nanopore and Illumina platform sequencing, allowing real-time, long-read analysis of your microbiome. This analysis can be performed using various targeted and comprehensive sequencing approaches.
Focuses on the 16S rRNA gene to identify and profile bacteria with high accuracy.
Provides a comprehensive view of the microbiome at both species and functional levels.
